HIMS - Hims & Hers Health, Inc.
NYSE
->
Consumer Defensive
->
Household & Personal Products
San Francisco,
United States
Type: Equity
HIMS price evolution
HIMS
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $97.52 | $58.85 | $66.27 | $49.6 |
| Short term investments | $124.32 | $154.5 | $127.72 | $135.65 |
| Net receivables | $4.23 | $3.9 | $4.47 | |
| Inventory | $22.46 | $21.99 | $21.42 | $20.7 |
| Total current assets | $265.05 | $250.22 | $234.65 | $225.53 |
| Long term investments | ||||
| Property, plant & equipment | $45.73 | $32.54 | $4.74 | $4.55 |
| Goodwill & intangible assets | $129.46 | $130.18 | $130.84 | $131.79 |
| Total noncurrent assets | $176.13 | $163.65 | $155.24 | $150.78 |
| Total investments | $124.32 | $154.5 | $127.72 | $135.65 |
| Total assets | $441.19 | $413.87 | $389.88 | $376.31 |
| Current liabilities | ||||
| Accounts payable | $43.07 | $42 | $38.27 | $37.61 |
| Deferred revenue | $7.73 | $4.39 | $2.06 | $2.87 |
| Short long term debt | $1.28 | $1.93 | $1.84 | $1.69 |
| Total current liabilities | $88.47 | $82.55 | $66.55 | $56.28 |
| Long term debt | $8.67 | $2.75 | $3.25 | $3.22 |
| Total noncurrent liabilities | $8.69 | $2.76 | $3.27 | $7.28 |
| Total debt | $9.95 | $4.68 | $5.09 | $4.9 |
| Total liabilities | $97.16 | $85.3 | $69.81 | $63.56 |
| Shareholders' equity | ||||
| Retained earnings | -$368.18 | -$369.42 | -$361.85 | -$354.7 |
| Other shareholder equity | -$0.12 | -$0.13 | -$0.26 | -$0.11 |
| Total shareholder equity | $344.03 | $328.56 | $320.07 | $312.75 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $97.52 | $47.63 | $72.64 | $27.34 |
| Short term investments | $124.32 | $132.85 | $175.49 | $72.86 |
| Net receivables | $3.2 | $3.58 | ||
| Inventory | $22.46 | $21.6 | $13.56 | $3.54 |
| Total current assets | $265.05 | $216.6 | $269.9 | $113.08 |
| Long term investments | ||||
| Property, plant & equipment | $45.73 | $16.1 | $5.11 | |
| Goodwill & intangible assets | $129.46 | $132.72 | $136.77 | |
| Total noncurrent assets | $176.13 | $149.75 | $150.68 | $5.61 |
| Total investments | $124.32 | $132.85 | $175.49 | $72.86 |
| Total assets | $441.19 | $366.3 | $420.58 | $118.7 |
| Current liabilities | ||||
| Accounts payable | $43.07 | $32.4 | $19.64 | $8.07 |
| Deferred revenue | $7.73 | $1.47 | $3.19 | $1.27 |
| Short long term debt | $1.28 | $1.66 | $1.36 | |
| Total current liabilities | $88.47 | $47.9 | $79.22 | $15.23 |
| Long term debt | $8.67 | $3.65 | $4.12 | |
| Total noncurrent liabilities | $8.69 | $6.66 | $6.75 | $0.38 |
| Total debt | $9.95 | $5.31 | $5.48 | |
| Total liabilities | $97.16 | $54.6 | $85.97 | $15.61 |
| Shareholders' equity | ||||
| Retained earnings | -$368.18 | -$344.6 | -$278.95 | -$171.29 |
| Other shareholder equity | -$0.12 | -$0.3 | -$0.14 | -$0.01 |
| Total shareholder equity | $344.03 | $311.74 | $334.62 | -$146.87 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $246.62 | $226.7 | $207.91 | $190.77 |
| Cost of revenue | $42.56 | $39.39 | $37.75 | $37.34 |
| Gross Profit | $204.06 | $187.31 | $170.16 | $153.43 |
| Operating activities | ||||
| Research & development | $13.4 | $12.27 | $11.8 | $10.75 |
| Selling, general & administrative | $158.21 | $151.98 | $138.36 | $127.76 |
| Total operating expenses | $204.46 | $195.86 | $179.39 | $164.69 |
| Operating income | -$0.4 | -$8.55 | -$9.24 | -$11.26 |
| Income from continuing operations | ||||
| EBIT | $2.2 | -$6.92 | -$7.17 | -$9.68 |
| Income tax expense | $0.95 | $0.65 | -$0.01 | $0.39 |
| Interest expense | ||||
| Net income | ||||
| Net income | $1.25 | -$7.57 | -$7.16 | -$10.07 |
| Income (for common shares) | $1.25 | -$7.57 | -$7.16 | -$10.07 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $872 | $526.92 | $271.88 | $148.76 |
| Cost of revenue | $157.05 | $118.19 | $67.38 | $39.31 |
| Gross Profit | $714.95 | $408.72 | $204.49 | $109.45 |
| Operating activities | ||||
| Research & development | $48.23 | $29.24 | ||
| Selling, general & administrative | $576.32 | $370.78 | $319.54 | $124.59 |
| Total operating expenses | $744.4 | $477.42 | $319.54 | $124.59 |
| Operating income | -$29.45 | -$68.7 | -$115.04 | -$15.14 |
| Income from continuing operations | ||||
| EBIT | -$21.57 | -$65.71 | -$110.8 | -$17.98 |
| Income tax expense | $1.98 | -$0.03 | -$3.14 | $0.13 |
| Interest expense | $0.01 | |||
| Net income | ||||
| Net income | -$23.55 | -$65.68 | -$107.66 | -$18.11 |
| Income (for common shares) | -$23.55 | -$65.68 | -$107.66 | -$18.11 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $1.25 | -$7.57 | -$7.16 | -$10.07 |
| Operating activities | ||||
| Depreciation | $3.17 | $2.86 | $2.84 | $2.56 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $17.79 | $17.28 | $16.84 | $14.17 |
| Total cash flows from operations | $21.98 | $25.19 | $16.83 | $9.48 |
| Investing activities | ||||
| Capital expenditures | -$11.2 | -$5.92 | -$6.86 | -$2.51 |
| Investments | $31.89 | -$25.14 | $9.24 | -$1.6 |
| Total cash flows from investing | $20.7 | -$31.06 | $2.37 | -$4.11 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.03 | $1.13 | $1.21 | $0.24 |
| Net borrowings | ||||
| Total cash flows from financing | -$3.96 | -$1.56 | -$2.54 | -$3.41 |
| Effect of exchange rate | -$0.05 | $0.01 | $0.01 | $0.01 |
| Change in cash and equivalents | $38.67 | -$7.42 | $16.67 | $1.97 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$23.55 | -$65.68 | -$107.66 | -$18.11 |
| Operating activities | ||||
| Depreciation | $11.44 | $9.08 | $5.58 | $1.06 |
| Business acquisitions & disposals | -$0.46 | -$46.47 | ||
| Stock-based compensation | $66.08 | $42.82 | $67.21 | $5.83 |
| Total cash flows from operations | $73.48 | -$26.53 | -$34.41 | -$2.48 |
| Investing activities | ||||
| Capital expenditures | -$26.49 | -$7.25 | -$5.01 | -$4.23 |
| Investments | $14.39 | $42.41 | -$104.79 | -$35.47 |
| Total cash flows from investing | -$12.11 | $34.7 | -$156.27 | -$39.7 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.62 | $3.42 | $252.7 | $0.68 |
| Net borrowings | $1.19 | -$1.51 | ||
| Total cash flows from financing | -$11.47 | -$33.13 | $235.04 | $47.74 |
| Effect of exchange rate | -$0.01 | -$0.05 | -$0.07 | -$0.01 |
| Change in cash and equivalents | $49.89 | -$25.01 | $44.29 | $5.55 |
News
Fundamentals
| Market cap | $2.65B |
|---|---|
| Enterprise value | $2.56B |
| Shares outstanding | 213.48M |
| Revenue | $872.00M |
|---|---|
| EBITDA | -$10.13M |
| EBIT | -$21.57M |
| Net Income | -$23.55M |
| Revenue Q/Q | 47.50% |
| Revenue Y/Y | 65.49% |
| P/E ratio | -112.52 |
|---|---|
| EV/Sales | 2.94 |
| EV/EBITDA | -252.79 |
| EV/EBIT | -118.76 |
| P/S ratio | 3.04 |
| P/B ratio | 7.70 |
| Book/Share | 1.61 |
| Cash/Share | 0.46 |
| EPS | -$0.11 |
|---|---|
| ROA | -5.81% |
| ROE | -7.21% |
| Debt/Equity | 0.28 |
|---|---|
| Net debt/EBITDA | 0.04 |
| Current ratio | 3.00 |
| Quick ratio | 2.74 |